NEW YORK (GenomeWeb) – NeoGenomics today reported that its fourth quarter revenues increased 36 percent with growth driven by both organic operations and its July 2014 acquisition of PathLogic.

The Ft. Myers, Fla.-based molecular testing clinical lab reported total revenues of $25 million for the three months ended Dec. 31, up from $18.3 million for the fourth quarter of 2013. It beat analysts' consensus estimate of $24.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.